Erica Clark, DO
Vascular Surgery · Spartanburg, SCNPI 1255635389
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,156 of the $7,411 with a category attached, or 69.6%. 40 manufacturers reported payments, led by Medtronic at 30.2% of the total. Reporting peaked in 2022 at $3,444 and has fallen 80.0% since, to $689 in 2025. That places this record below the midpoint for vascular surgery clinicians in SC, where the typical reported total is $7,261.
Across 152 payments — averaging $48.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Penumbra, Inc.$2K
- Silk Road Medical, Inc.$1K
- Endologix LLC$272
- Johnson & Johnson$232
- Lemaitre Vascular, Inc.$187
- plus $1K from 34 others
Across 1 payment — averaging $4920.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$5K
What the payments were for
- Consulting fees$6008%
- Travel & lodging$1,65522%
- Food & beverage$5,15670%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 54 | $2,241 |
| Penumbra, Inc. | 7 | $1,947 |
| Silk Road Medical, Inc. | 14 | $1,115 |
| Endologix LLC | 1 | $272 |
| Johnson & Johnson(2 entities) | 13 | $232 |
| Lemaitre Vascular, Inc. | 6 | $187 |
| Stryker | 3 | $172 |
| Shockwave Medical, Inc | 6 | $124 |
| Cvrx, Inc. | 1 | $95 |
| Inari Medical, Inc. | 5 | $81 |
| Contego Medical, Inc | 1 | $69 |
| Abbott | 3 | $63 |
| Globus Medical | 2 | $60 |
| Terumo Medical Corporation | 3 | $56 |
| Cardiva Medical, Inc. | 2 | $54 |
| Bard Peripheral Vascular, Inc. | 2 | $47 |
| Baxter Healthcare | 2 | $45 |
| Peerless Surgical Inc. | 1 | $42 |
| Philips North America LLC | 2 | $38 |
| Boston Scientific | 2 | $37 |
| Integra Lifesciences Corporation | 1 | $36 |
| Angiodynamics, Inc. | 1 | $31 |
| Getinge USA Sales, LLC | 1 | $30 |
| Biom'up France SAS | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| W. L. Gore & Associates, Inc. | 2 | $26 |
| Imperative Care, Inc | 1 | $24 |
| Kerecis Limited | 1 | $21 |
| Cordis US CORP. | 1 | $21 |
| Cagent Vascular Inc | 1 | $20 |
| Convatec Inc. | 1 | $20 |
| Smith+Nephew | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Veryan Medical Incorporated | 1 | $19 |
| Atricure, Inc. | 1 | $19 |
| Solventum Corporation | 1 | $17 |
| Artivion, Inc. | 1 | $15 |
| Thrombolex, Inc. | 1 | $14 |
| EKOS Corporation | 1 | $13 |
| Hydrofera LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$1,762
- ENROUTE Transcarotid Neuroprotection System$943
- ENROUTE Transcarotid Stent$943
- ENHANCE Transcarotid Peripheral Access Kit$600
- ENROUTE .014 Guidewire$600
- ENDURANT IIS$576
- Ovation iX Iliac Stent Graft$272
- AFX2 Bifurcated Endograft System$272
- Endurant$213
- ARTIX MT$166
- Valiant Captivia$161
- Heli-FX EndoAnchor System$131
- Valiant Navion$101
How this compares
$7,411 in reported general payments places this provider in the 50th percentile of 99 vascular surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 45 | $41,796 |
| EliquisApixaban | 24 | $23,316 |
| ClopidogrelClopidogrel Bisulfate | 183 | $1,901 |
| Cilostazol | 68 | $1,250 |
| Rosuvastatin Calcium | 25 | $666 |
| Enoxaparin Sodium | 11 | $548 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $232 | $41,79645 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 99 vascular surgery providers in South Carolina.
Other vascular surgery in Spartanburg
- Scott SilverSpartanburg$8K
- John RossOrangeburg$847K
- David DeatonColumbia$609K
- Mathew WoosterWest Columbia$443K
- Sagar GandhiGreenville$236K
- Ravi VeeraswamyCharleston$164K
- Gerald FortunaWest Columbia$143K
- Kristian HochbergCharleston$106K
- Joseph BlasGreenville$101K
- Thomas ApplebyNorth Charleston$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.